{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:00:28Z","timestamp":1788976828235,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli studi \"Magna Graecia\" di Catanzaro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Differentiating Progressive supranuclear palsy-Richardson\u2019s syndrome (PSP-RS) from PSP-Parkinsonism (PSP-P) may be extremely challenging. In this study, we aimed to distinguish these two PSP phenotypes using MRI structural data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sixty-two PSP-RS, 40 PSP-P patients and 33 control subjects were enrolled. All patients underwent brain 3\u00a0T-MRI; cortical thickness and cortical\/subcortical volumes were extracted using Freesurfer on T1-weighted images. We calculated the automated MR Parkinsonism Index (MRPI) and its second version including also the third ventricle width (MRPI 2.0) and tested their classification performance. We also employed a Machine learning (ML) classification approach using two decision tree-based algorithms (eXtreme Gradient Boosting [XGBoost] and Random Forest) with different combinations of structural MRI data in differentiating between PSP phenotypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MRPI and MRPI 2.0 had AUC of\u00a00.88 and 0.81, respectively, in differentiating PSP-RS from PSP-P. ML models demonstrated that the combination of MRPI and volumetric\/thickness data was more powerful than each feature alone. The two ML algorithms showed comparable results, and the best ML model in differentiating between PSP phenotypes used XGBoost with a combination of MRPI, cortical thickness and subcortical volumes (AUC 0.93\u2009\u00b1\u20090.04). Similar performance (AUC 0.93\u2009\u00b1\u20090.06) was also obtained in a sub-cohort of 59 early PSP patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The combined use of MRPI and volumetric\/thickness data was more accurate than each MRI feature alone in differentiating between PSP-RS and PSP-P. Our study supports the use of structural MRI to improve the early differential diagnosis between common PSP phenotypes, which may be relevant for prognostic implications and patient inclusion in clinical trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-023-11892-y","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T03:18:02Z","timestamp":1690600682000},"page":"5502-5515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Differentiating between common PSP phenotypes using structural MRI: a machine learning study"],"prefix":"10.1007","volume":"270","author":[{"given":"Andrea","family":"Quattrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Sarica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"Buonocore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Calomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Aracri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marida","family":"De Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basilio","family":"Vescio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2001-957X","authenticated-orcid":false,"given":"Aldo","family":"Quattrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"11892_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"11892_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI et al (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16:552\u2013563. https:\/\/doi.org\/10.1016\/S1474-4422(17)30157-6","journal-title":"Lancet Neurol"},{"key":"11892_CR3","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C et al (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758\u20131766. https:\/\/doi.org\/10.1002\/mds.26054","journal-title":"Mov Disord"},{"key":"11892_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00702-023-02591-z","volume":"130","author":"M Campagnolo","year":"2023","unstructured":"Campagnolo M, Weis L, Fogliano C et al (2023) Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes. J Neural Transm (Vienna) 130:97\u2013109. https:\/\/doi.org\/10.1007\/s00702-023-02591-z","journal-title":"J Neural Transm (Vienna)"},{"key":"11892_CR5","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00415-019-09324-x","volume":"266","author":"M Picillo","year":"2019","unstructured":"Picillo M, Cuoco S, Tepedino MF et al (2019) Motor, cognitive and behavioral differences in MDS PSP phenotypes. J Neurol 266:1727\u20131735. https:\/\/doi.org\/10.1007\/s00415-019-09324-x","journal-title":"J Neurol"},{"key":"11892_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","volume":"77","author":"E Jabbari","year":"2020","unstructured":"Jabbari E, Holland N, Chelban V et al (2020) Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome. JAMA Neurol 77:377\u2013387. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4347","journal-title":"JAMA Neurol"},{"key":"11892_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.parkreldis.2019.10.012","volume":"69","author":"A Shoeibi","year":"2019","unstructured":"Shoeibi A, Litvan I, Juncos JL et al (2019) Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism Relat Disord 69:34\u201339. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.012","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/mds.27666","volume":"34","author":"MJ Grimm","year":"2019","unstructured":"Grimm MJ, Respondek G, Stamelou M et al (2019) How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord 34:1228\u20131232. https:\/\/doi.org\/10.1002\/mds.27666","journal-title":"Mov Disord"},{"key":"11892_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.827338","volume":"13","author":"JJS-R de Gordoa","year":"2022","unstructured":"de Gordoa JJS-R, Zelaya V, Tellechea-Aramburo P et al (2022) Is the phenotype designation by PSP-MDS criteria stable throughout the disease course and consistent with tau distribution? Front Neurol 13:827338. https:\/\/doi.org\/10.3389\/fneur.2022.827338","journal-title":"Front Neurol"},{"issue":"11","key":"11892_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fneur.2020.00180","volume":"10","author":"P Alster","year":"2020","unstructured":"Alster P, Madetko N, Koziorowski D, Friedman A (2020) Progressive supranuclear palsy-parkinsonism predominant (PSP-P)\u2014a clinical challenge at the boundaries of PSP and Parkinson\u2019s disease (PD). Front Neurol 10(11):180. https:\/\/doi.org\/10.3389\/fneur.2020.00180","journal-title":"Front Neurol"},{"key":"11892_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00702-010-0563-8","volume":"118","author":"K Srulijes","year":"2011","unstructured":"Srulijes K, Mallien G, Bauer S et al (2011) In vivo comparison of Richardson\u2019s syndrome and progressive supranuclear palsy-parkinsonism. J Neural Transm (Vienna) 118:1191\u20131197. https:\/\/doi.org\/10.1007\/s00702-010-0563-8","journal-title":"J Neural Transm (Vienna)"},{"key":"11892_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.02.022","volume":"63","author":"A Quattrone","year":"2019","unstructured":"Quattrone A, Caligiuri ME, Morelli M et al (2019) Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: a multimodal MRI study. Parkinsonism Relat Disord 63:124\u2013130. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.022","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR13","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/mds.26572","volume":"31","author":"BR Bloem","year":"2016","unstructured":"Bloem BR, Marinus J, Almeida Q et al (2016) Measurement instruments to assess posture, gait, and balance in Parkinson\u2019s disease: critique and recommendations. Mov Disord 31:1342\u20131355. https:\/\/doi.org\/10.1002\/mds.26572","journal-title":"Mov Disord"},{"issue":"7","key":"11892_CR14","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/mds.20925","volume":"21","author":"AL Hunt","year":"2006","unstructured":"Hunt AL, Sethi KD (2006) The pull test: a history. Mov Disord 21(7):894\u2013899. https:\/\/doi.org\/10.1002\/mds.20925. (PMID: 16685683)","journal-title":"Mov Disord"},{"key":"11892_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.parkreldis.2016.12.009","volume":"35","author":"B Bluett","year":"2017","unstructured":"Bluett B, Litvan I, Cheng S et al (2017) Understanding falls in progressive supranuclear palsy. Parkinsonism Relat Disord 35:75\u201381. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.12.009","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR16","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/mds.25674","volume":"28","author":"M Amboni","year":"2013","unstructured":"Amboni M, Barone P, Hausdorff JM (2013) Cognitive contributions to gait and falls: evidence and implications. Mov Disord 28:1520\u20131533. https:\/\/doi.org\/10.1002\/mds.25674","journal-title":"Mov Disord"},{"key":"11892_CR17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.28007","volume":"35","author":"S Nigro","year":"2020","unstructured":"Nigro S, Antonini A, Vaillancourt DE et al (2020) Automated MRI classification in progressive supranuclear palsy: a large international cohort study. Mov Disord 35:976\u2013983. https:\/\/doi.org\/10.1002\/mds.28007","journal-title":"Mov Disord"},{"key":"11892_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.parkreldis.2019.08.007","volume":"66","author":"K Zhang","year":"2019","unstructured":"Zhang K, Liang Z, Wang C et al (2019) Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 66:176\u2013181. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.08.007","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/brainsci12070949","volume":"12","author":"A Quattrone","year":"2022","unstructured":"Quattrone A, Morelli M, Bianco MG et al (2022) Magnetic resonance planimetry in the differential diagnosis between Parkinson\u2019s disease and progressive supranuclear palsy. Brain Sci 12:949. https:\/\/doi.org\/10.3390\/brainsci12070949","journal-title":"Brain Sci"},{"key":"11892_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/mds.28060","volume":"35","author":"DB Archer","year":"2020","unstructured":"Archer DB, Mitchell T, Burciu RG et al (2020) Magnetic resonance imaging and neurofilament light in the differentiation of Parkinsonism. Mov Disord 35:1388\u20131395. https:\/\/doi.org\/10.1002\/mds.28060","journal-title":"Mov Disord"},{"key":"11892_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/mds.28348","volume":"36","author":"L Chougar","year":"2021","unstructured":"Chougar L, Faouzi J, Pyatigorskaya N et al (2021) Automated categorization of parkinsonian syndromes using magnetic resonance imaging in a clinical setting. Mov Disord 36:460\u2013470. https:\/\/doi.org\/10.1002\/mds.28348","journal-title":"Mov Disord"},{"key":"11892_CR22","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/mds.26715","volume":"31","author":"HJ Huppertz","year":"2016","unstructured":"Huppertz HJ, M\u00f6ller L, S\u00fcdmeyer M et al (2016) Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord 31:1506\u20131517. https:\/\/doi.org\/10.1002\/mds.26715","journal-title":"Mov Disord"},{"key":"11892_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.parkreldis.2018.02.004","volume":"49","author":"M Seki","year":"2018","unstructured":"Seki M, Seppi K, Mueller C et al (2018) Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy. Parkinsonism Relat Disord 49:81\u201387. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.004. (Epub 2018 Feb 7 PMID: 29463454)","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR24","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/mds.22279","volume":"23","author":"G Nicoletti","year":"2008","unstructured":"Nicoletti G, Tonon C, Lodi R et al (2008) Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson\u2019s disease. Mov Disord 23:2370\u20132376. https:\/\/doi.org\/10.1002\/mds.22279","journal-title":"Mov Disord"},{"key":"11892_CR25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1148\/radiol.2019190406","volume":"293","author":"N Spotorno","year":"2019","unstructured":"Spotorno N, Hall S, Irwin DJ et al (2019) Diffusion tensor MRI to distinguish progressive supranuclear palsy from \u03b1-synucleinopathies. Radiology 293:646\u2013653. https:\/\/doi.org\/10.1148\/radiol.2019190406","journal-title":"Radiology"},{"key":"11892_CR26","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/mds.28217","volume":"35","author":"G Mart\u00ed-Andr\u00e9s","year":"2020","unstructured":"Mart\u00ed-Andr\u00e9s G, van Bommel L, Meles SK et al (2020) Multicenter validation of metabolic abnormalities related to PSP according to the MDS-PSP criteria. Mov Disord 35:2009\u20132018. https:\/\/doi.org\/10.1002\/mds.28217","journal-title":"Mov Disord"},{"key":"11892_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11556-3","author":"J Jin","year":"2023","unstructured":"Jin J, Su D, Zhang J et al (2023) Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-022-11556-3","journal-title":"J Neurol"},{"key":"11892_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.016","volume":"54","author":"A Quattrone","year":"2018","unstructured":"Quattrone A, Morelli M, Nigro S et al (2018) A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson\u2019s disease. Parkinsonism Relat Disord 54:3\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.016","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR29","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mds.28992","volume":"37","author":"A Quattrone","year":"2022","unstructured":"Quattrone A, Bianco MG, Antonini A et al (2022) Development and validation of automated magnetic resonance Parkinsonism index 2.0 to distinguish progressive supranuclear Palsy-Parkinsonism from Parkinson\u2019s disease. Mov Disord 37:1272\u20131281. https:\/\/doi.org\/10.1002\/mds.28992","journal-title":"Mov Disord"},{"key":"11892_CR30","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMp1606181","volume":"375","author":"Z Obermeyer","year":"2016","unstructured":"Obermeyer Z, Emanuel EJ (2016) Predicting the future\u2014big data, machine learning, and clinical medicine. N Engl J Med 375:1216\u20131219. https:\/\/doi.org\/10.1056\/NEJMp1606181","journal-title":"N Engl J Med"},{"key":"11892_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s12021-022-09572-9","volume":"20","author":"NM Singh","year":"2022","unstructured":"Singh NM, Harrod JB, Subramanian S et al (2022) How machine learning is powering neuroimaging to improve brain health. Neuroinformatics 20:943\u2013964. https:\/\/doi.org\/10.1007\/s12021-022-09572-9","journal-title":"Neuroinformatics"},{"key":"11892_CR32","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1002\/acn3.50947","volume":"6","author":"J Benito-Le\u00f3n","year":"2019","unstructured":"Benito-Le\u00f3n J, Louis ED, Mato-Abad V et al (2019) A data mining approach for classification of orthostatic and essential tremor based on MRI-derived brain volume and cortical thickness. Ann Clin Transl Neurol 6:2531\u20132543. https:\/\/doi.org\/10.1002\/acn3.50947","journal-title":"Ann Clin Transl Neurol"},{"key":"11892_CR33","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1007\/s00415-023-11747-6","volume":"270","author":"MG Bianco","year":"2023","unstructured":"Bianco MG, Quattrone A, Sarica A et al (2023) Cortical involvement in essential tremor with and without rest tremor: a machine learning study. J Neurol 270:4004\u20134012. https:\/\/doi.org\/10.1007\/s00415-023-11747-6","journal-title":"J Neurol"},{"key":"11892_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Mach Learn 45:5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324","journal-title":"Mach Learn"},{"key":"11892_CR35","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C (2016) XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining. association for computing machinery, New York, pp 785\u2013794","DOI":"10.1145\/2939672.2939785"},{"key":"11892_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/wnl.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1\u20139. https:\/\/doi.org\/10.1212\/wnl.47.1.1","journal-title":"Neurology"},{"key":"11892_CR37","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams DR, de Silva R, Paviour DC et al (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain 128:1247\u20131258. https:\/\/doi.org\/10.1093\/brain\/awh488","journal-title":"Brain"},{"key":"11892_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1148\/radiol.2017161216","volume":"285","author":"N Miskin","year":"2017","unstructured":"Miskin N, Patel H, Franceschi AM et al (2017) Diagnosis of normal-pressure hydrocephalus: use of traditional measures in the era of volumetric MR imaging. Radiology 285:197\u2013205. https:\/\/doi.org\/10.1148\/radiol.2017161216","journal-title":"Radiology"},{"key":"11892_CR39","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"11892_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"11892_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state:\u201d a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"11892_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.02.046","volume":"63","author":"M Salsone","year":"2019","unstructured":"Salsone M, Caligiuri ME, Vescio V et al (2019) Microstructural changes of normal-appearing white matter in vascular Parkinsonism. Parkinsonism Relat Disord 63:60\u201365. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.046","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9:179\u2013194. https:\/\/doi.org\/10.1006\/nimg.1998.0395","journal-title":"Neuroimage"},{"key":"11892_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77","journal-title":"BMC Bioinformatics"},{"key":"11892_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.parkreldis.2022.08.007","volume":"103","author":"MG Bianco","year":"2022","unstructured":"Bianco MG, Quattrone A, Sarica A et al (2022) Cortical atrophy distinguishes idiopathic normal-pressure hydrocephalus from progressive supranuclear palsy: a machine learning approach. Parkinsonism Relat Disord 103:7\u201314. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.08.007","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/jnp.12232","volume":"15","author":"MG Vaccaro","year":"2021","unstructured":"Vaccaro MG, Sarica A, Quattrone A et al (2021) Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: a Machine Learning approach. J Neuropsychol 15:301\u2013318. https:\/\/doi.org\/10.1111\/jnp.12232","journal-title":"J Neuropsychol"},{"key":"11892_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2105-8-25","volume":"8","author":"C Strobl","year":"2007","unstructured":"Strobl C, Boulesteix AL, Zeileis A et al (2007) Bias in random forest variable importance measures: illustrations, sources and a solution. BMC Bioinformatics 8:25. https:\/\/doi.org\/10.1186\/1471-2105-8-25","journal-title":"BMC Bioinformatics"},{"key":"11892_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102152","volume":"25","author":"JL Whitwell","year":"2020","unstructured":"Whitwell JL, Tosakulwong N, Botha H et al (2020) Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Neuroimage Clin. 25:102152. https:\/\/doi.org\/10.1016\/j.nicl.2019.102152","journal-title":"Neuroimage Clin."},{"key":"11892_CR49","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1460-9568.2010.07304.x","volume":"32","author":"F Agosta","year":"2010","unstructured":"Agosta F, Kosti\u0107 VS, Galantucci S et al (2010) The in vivo distribution of brain tissue loss in Richardson\u2019s syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32:640\u2013647. https:\/\/doi.org\/10.1111\/j.1460-9568.2010.07304.x","journal-title":"Eur J Neurosci"},{"key":"11892_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2020.02.007","volume":"72","author":"T Potrusil","year":"2020","unstructured":"Potrusil T, Krismer F, Beliveau V et al (2020) Diagnostic potential of automated tractography in progressive supranuclear palsy variants. Parkinsonism Relat Disord 72:65\u201371. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.007","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR51","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1016\/j.neurobiolaging.2012.02.002","volume":"33","author":"F Agosta","year":"2012","unstructured":"Agosta F, Pievani M, Svetel M et al (2012) Diffusion tensor MRI contributes to differentiate Richardson\u2019s syndrome from PSP-parkinsonism. Neurobiol Aging 33:2817\u20132826. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.02.002","journal-title":"Neurobiol Aging"},{"key":"11892_CR52","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s00415-020-10360-1","volume":"268","author":"JL Whitwell","year":"2021","unstructured":"Whitwell JL, Tosakulwong N, Clark HM et al (2021) Diffusion tensor imaging analysis in three progressive supranuclear palsy variants. J Neurol 268:3409\u20133420. https:\/\/doi.org\/10.1007\/s00415-020-10360-1","journal-title":"J Neurol"},{"key":"11892_CR53","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3174\/ajnr.A5048","volume":"38","author":"G Nicoletti","year":"2017","unstructured":"Nicoletti G, Caligiuri ME, Cherubini A et al (2017) A fully automated, atlas-based approach for superior cerebellar peduncle evaluation in progressive supranuclear palsy phenotypes. AJNR Am J Neuroradiol 38:523\u2013530. https:\/\/doi.org\/10.3174\/ajnr.A5048","journal-title":"AJNR Am J Neuroradiol"},{"key":"11892_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/mds.23293","volume":"26","author":"G Longoni","year":"2011","unstructured":"Longoni G, Agosta F, Kosti\u0107 VS et al (2011) MRI measurements of brainstem structures in patients with Richardson\u2019s syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson\u2019s disease. Mov Disord 26:247\u2013255. https:\/\/doi.org\/10.1002\/mds.23293","journal-title":"Mov Disord"},{"key":"11892_CR55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jnnp-2019-321354","volume":"91","author":"M Picillo","year":"2020","unstructured":"Picillo M, Tepedino MF, Abate F et al (2020) Midbrain MRI assessments in progressive supranuclear palsy subtypes. J Neurol Neurosurg Psychiatry 91:98\u2013103. https:\/\/doi.org\/10.1136\/jnnp-2019-321354","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11892_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2020.11.019","volume":"82","author":"B Heim","year":"2021","unstructured":"Heim B, Mangesius S, Krismer F et al (2021) Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism. Parkinsonism Relat Disord 82:87\u201391. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.019","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/mds.23295","volume":"26","author":"EC Schofield","year":"2011","unstructured":"Schofield EC, Hodges JR, Macdonald V et al (2011) Cortical atrophy differentiates Richardson\u2019s syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord 26:256\u2013263. https:\/\/doi.org\/10.1002\/mds.23295","journal-title":"Mov Disord"},{"issue":"Pt 6","key":"11892_CR58","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","volume":"130","author":"DR Williams","year":"2007","unstructured":"Williams DR, Holton JL, Strand C et al (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson\u2019s syndrome. Brain 130(Pt 6):1566\u20131576. https:\/\/doi.org\/10.1093\/brain\/awm104. (PMID: 17525140)","journal-title":"Brain"},{"key":"11892_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ et al (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99\u2013119. https:\/\/doi.org\/10.1007\/s00401-020-02158-2","journal-title":"Acta Neuropathol"},{"key":"11892_CR60","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.9588","volume":"5","author":"I Ill\u00e1n-Gala","year":"2022","unstructured":"Ill\u00e1n-Gala I, Nigro S, VandeVrede L et al (2022) Diagnostic accuracy of magnetic resonance imaging measures of brain atrophy across the spectrum of progressive supranuclear palsy and corticobasal degeneration. JAMA Netw Open 5:e229588. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.9588","journal-title":"JAMA Netw Open"},{"key":"11892_CR61","doi-asserted-by":"publisher","first-page":"fcac098","DOI":"10.1093\/braincomms\/fcac098","volume":"4","author":"WJ Scotton","year":"2022","unstructured":"Scotton WJ, Bocchetta M, Todd E et al (2022) A data-driven model of brain volume changes in progressive supranuclear palsy. Brain Commun 4:fcac098. https:\/\/doi.org\/10.1093\/braincomms\/fcac098","journal-title":"Brain Commun"},{"key":"11892_CR62","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s10462-020-09896-5","volume":"54","author":"C Bent\u00e9jac","year":"2021","unstructured":"Bent\u00e9jac C, Cs\u00f6rg\u0151 A, Mart\u00ednez-Mu\u00f1oz G (2021) A comparative analysis of gradient boosting algorithms. Artif Intell Rev 54:1937\u20131967","journal-title":"Artif Intell Rev"},{"key":"11892_CR63","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00415-014-7384-x","volume":"261","author":"M Jecmenica-Lukic","year":"2014","unstructured":"Jecmenica-Lukic M, Petrovic IN, Pekmezovic T et al (2014) Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study. J Neurol 261:1575\u20131583. https:\/\/doi.org\/10.1007\/s00415-014-7384-x","journal-title":"J Neurol"},{"key":"11892_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.01.015","volume":"84","author":"M Guasp","year":"2021","unstructured":"Guasp M, Molina-Porcel L, Painous C et al (2021) Association of PSP phenotypes with survival: a brain-bank study. Parkinsonism Relat Disord 84:77\u201381. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.01.015","journal-title":"Parkinsonism Relat Disord"},{"key":"11892_CR65","doi-asserted-by":"publisher","first-page":"fcab206","DOI":"10.1093\/braincomms\/fcab206","volume":"3","author":"D Street","year":"2021","unstructured":"Street D, Malpetti M, Rittman T et al (2021) Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants. Brain Commun. 3:fcab206. https:\/\/doi.org\/10.1093\/braincomms\/fcab206","journal-title":"Brain Commun."}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11892-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11892-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11892-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:05:49Z","timestamp":1697274349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11892-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["11892"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11892-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All patients in our study gave their informed consent prior to their inclusion in the study. Approval of our study was obtained from the ethics committee of Magna Graecia University review board, Catanzaro, Italy. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}